Delivery Order SPE2DB20D3101-SPE2DB25FREK7
Award Date
3/13/25
Potential Completion Date
3/14/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,391.63, is for the delivery of ATOMOXETINE HCL 40 MG CAPSULE 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 15, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,727.36, is for the delivery of ATOMOXETINE HCL 40 MG CAPSULE 30S, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of December 20, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,134.15 firm fixed-price delivery order is for the supply of ATOMOXETINE HCL 18 MG CAPSULE 30S, a generic medication. The contract has an ultimate completion date of March 10, 2025 and was awarded on March 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with ID SPE2DB20D2002|SPE2DB25FL21N, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,281.94 firm fixed-price delivery order is for the supply of ATOMOXETINE HCL 40 MG CAPSULE 30S, a type of prescription medication. The contract has an ultimate completion date of February 21, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, with an ID of SPE2DB22D3102|SPE2DB24FL1CQ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564591314 - ATOMOXETINE HCL 40 MG CAPSULE 30S, a pharmaceutical product, with a ceiling value of $1,064.74 and a completion date of May 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,432.16 firm fixed-price delivery order is for the supply of 4556432935 ATOMOXETINE HCL 40 MG CAPSULE 30S. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company...
This federal contract award is a delivery order (SPE2DB20D3104|SPE2DB24FV6Q3) worth $1,809.62, issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4564437085 ATOMOXETINE HCL 40 MG CAPSULE 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides delivery orders for the supply of ATOMOXETINE HCL 40 MG CAPSULE 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,282.76 and a completion date of September 26, 2024. It is a Firm Fixed Price, Delivery Order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, valued at $3,615.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, for the supply of ATOMOXETINE HCL 10 MG CAPSULE 30S, a medication. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, with an ID of SPE2DB20D3505|SPE2DB22FU1B2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,014.30 firm fixed-price delivery order is for the supply of 4557922882 - ATOMOXETINE HCL 40 MG CAPSULE 30S, a prescription medication. The award is not associated with a set-aside program and has an ultimate completion date of July 28, 2022. AmerisourceBergen Drug Corp is a subsidiary of Cencora,...